David Lemus Net Worth

David Lemus biography

David Jakob Lemus CPA serves as Independent Director of the Company. and development of T-Cell-Receptor based immunotherapies. Prior to that time, at Sigma Tau Pharmaceuticals, Inc., he served as Chief Executive Officer from January 2013 to July 2015, as Chief Operating Officer from March 2012 to December 2012, and as V.P. Finance from July 2011 to February 2012. Previous to this, Mr. Lemus served as Chief Financial Officer and Executive V.P. of MorphoSys AG from January 1998 to May 2011. Prior to his role at MorphoSys AG, he held various positions, including Operations Manager and Controller (Pharma International Division) and Global IT Project Manager (Pharma Division) at Hoffman La Roche, Group Treasurer of Lindt & Spruengli AG and Treasury Consultant for Electrolux AB.

What is the salary of David Lemus?

As the Independent Director of Sorrento Therapeutics Inc, the total compensation of David Lemus at Sorrento Therapeutics Inc is 291,400$. There are 7 executives at Sorrento Therapeutics Inc getting paid more, with Jaisim Shah having the highest compensation of 10,971,100$.

How old is David Lemus?

David Lemus is 57, he's been the Independent Director of Sorrento Therapeutics Inc since 2017. There are 4 older and 6 younger executives at Sorrento Therapeutics Inc. The oldest executive at Sorrento Therapeutics Inc is Dr. Michael A. Royal, 67, who is the SVP & Chief Medical Officer.

What's David Lemus's mailing address?

David's mailing address filed with the SEC is C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTORS PLACE, SAN DIEGO, CA, 92121.

Insiders trading at Sorrento Therapeutics Inc

Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over 17,198,839$ worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth 10,703,222$ . The most active insiders traders include Jane Ph D Hsiao、Edgar Lee、Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of 2,947$. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth 179,554$.

What does Sorrento Therapeutics Inc do?

sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.

Sorrento Therapeutics Inc executives and stock owners

Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include:

• Jaisim Shah,
  Director
• Henry Ji,
  Chairman of the Board, President, Chief Executive Officer, Co-Founder
• Dr. Henry H. Ji Ph.D.,
  Chairman, Pres & CEO
• Najjam Asghar,
  Sr. VP & CFO
• Kim Janda,
  Director
• Yue Wu,
  Independent Director
• Dorman Followwill,
  Lead Independent Director
• David Lemus,
  Independent Director
• Robin Smith,
  Independent Director
• Edgar Lee,
  Independent Director
• Najjam Asghar,
  Chief Financial Officer
• William J. Farley,
  VP of Sales & Bus. Devel.
• Dr. Robert D. Allen Ph.D.,
  Sr. VP of Antiviral & Immunotherapy
• Brian Cooley,
  Sr. VP of Lymphatic Drug Delivery BU Leader
• Dr. Shawn Sahebi Ph.D.,
  Sr. VP of Strategy & Analytics
• Dr. Mark R. Brunswick,
  Sr. VP of Regulatory Affairs
• Dr. Alexis Nahama,
  Sr. VP & Head of RTX Program
• Dr. Michael A. Royal,
  SVP & Chief Medical Officer
• Bill Farley,
  VP of Sales & Bus. Devel.
• Brian Sun,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Jane Ph D Hsiao,
  Director
• Management Ltd Abg Srne Ltd...,
  
• Douglas O Ebersole,
  Director
• Jeffrey Su,
  Executive VP and COO
• Kevin Herde,
  Executive VP and CFO
• William S Marth,
  Director
• Management Ltd Abg Srne Ltd...,
  
• George K Ng,
  See Remarks
• Patrick Chan Soon Shiong Fa...,
  
• Jerome B Zeldis,
  See Remarks
• David H Deming,
  Director
• Antonius Schuh,
  Chairman and CEO
• Steve Zaniboni,
  Director
• Curtis Lockshin,
  Director
• Donald R Scifres,
  10% owner
• Diane D S Tang Liu,
  Director
• Glenn L Halpryn,
  Director
• Charles P Rodi,
  VP, Research & Development
• Martina Molsbergen,
  VP, Business Development
• Dean Ferrigno,
  Chief Accounting Officer
• Pacific Med Tech (Bvi) Ltd ...,
  
• Management Ltd Abg Srne Ltd...,
  
• Management Ltd Abg Ii So Lt...,
  
• Jiong Shao,
  Chief Financial Officer
• Zhenwei Miao,
  Chief Technology Officer
• George Uy,
  Chief Commercial Officer
• Patrickmp 13 Ventures, Llc ...,
  
• Michael Scott Salka,
  Director
• Health, Inc. Opko,
  10% owner
• Mark Durand,
  Director
• Richard G Vincent,
  Chief Financial Officer
• Cam Gallagher,
  Director
• David Ritchie Webb,
  Director
• Ernst Guenter Afting,
  Director
• Vuong Trieu,
  CSO
• Elizabeth Czerepak,
  EVP & Chief Financial Officer
• Tammy Reilly,
  Director